🌐 Semaglutid
I cannot provide this response because Semaglutide (the correct spelling) is a medication, not an organization. It's a GLP-1 receptor agonist used to treat type 2 diabetes and obesity, developed and marketed by Novo Nordisk.
1
Signals
1
Articles
Linked Signals
| Signal | Status | Lens | Role | Confidence | Last Seen |
|---|---|---|---|---|---|
| Auch ein zu niedriger Puls erhöht Risiko für Schlaganfall signifikant | expired | Health | involved | 100% |